Garry L. Schwartz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Garry L. Schwartz has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Stephen T. Turner
Division of Nephrology and Hypertension, Department of Internal Medicine, College of Medicine, Mayo Clinic , Rochester, Minnesota
6 shared publicationsEric Boerwinkle
Human Genetics and Institute of Molecular Medicine, University of Texas Health Science Center , Houston, Texas
3 shared publicationsArlene B. Chapman
Renal Division, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia
2 shared publications- Clifford R. Jack
Department of Radiology, Mayo Clinic, Rochester, MN; and
2 shared publications - Kent R. Bailey
Division of Biomedical Statistics and Informatics Endocrine Research Unit Mayo Clinic Rochester Minnesota USA
2 shared publications Thomas Mosley
From the Division of Nephrology and Hypertension (G.L.S., S.T.T., V.J.C.), the Department of Diagnostic Radiology (C.R.J.), the Department of Neurology (D.S.K.), and the Department of Health Sciences Research (K.R.B.), Mayo Clinic College of Medicine, Rochester, Minn; and the Department of Geriatric Medicine (T.M.), University of Mississippi, Jackson
2 shared publications
Latest Publications
- 1 December 2020
- Published by Wolters Kluwer Health in Hypertension
- Vol. 76 (6) , 1658-1663
Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs
- 1 December 2020
- Published by Wolters Kluwer Health in Hypertension
- Vol. 76 (6) , 1658-1663
Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs
- 1 September 2018
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 12 (9) , 641-643
Clinical value of plasma renin activity and aldosterone concentration in the evaluation of secondary hypertension, a case of reninoma
- 1 September 2018
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 12 (9) , 641-643
Clinical value of plasma renin activity and aldosterone concentration in the evaluation of secondary hypertension, a case of reninoma
- 1 September 2017
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 70 (3) , 311-314
Treating to Target in Older Hypertensive Patients: Where Is the Bull’s Eye?
- 1 September 2017
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 70 (3) , 311-314
Treating to Target in Older Hypertensive Patients: Where Is the Bull’s Eye?
- 25 January 2017
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 11 (3) , 134-135
Genetic testing helps to confirm the diagnosis and initiate appropriate treatment, a case of Liddle syndrome
- 25 January 2017
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 11 (3) , 134-135
Genetic testing helps to confirm the diagnosis and initiate appropriate treatment, a case of Liddle syndrome
- Open Access
- 16 April 2013
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 26 (8) , 957-964
The Role of Plasma Renin Activity, Age, and Race in Selecting Effective Initial Drug Therapy for Hypertension
Strategies for initial drug therapy of hypertension are a thiazide diuretic for all or drug selection based on age/race criteria or on plasma renin activity (PRA). It is uncertain which of these strategies will achieve the highest control rate among patients with stage 1 essential hypertension. We sought to compare control rates among 3 drug selection strategies: (i) thiazide diuretic for all, (ii) thiazide diuretic for all black subjects and white subjects aged ≥50 years and a renin-angiotensin system blocker for white subjects aged P < 0.001) and 53.8% with the thiazide for all strategy (P < 0.001). This was also true in each racial subgroup (in black subjects: 62.1% vs. 55.2% for the other 2 strategies, P = 0.02; in white subjects: 76.3% vs. 67.1% with the age/race strategy (P < 0.001) and 52.4% with the thiazide for all strategy (P < 0.001)). This exploratory analysis suggests that choice of initial therapy for hypertension using a PRA strategy may be associated with higher control rates than alternative strategies recommended in current guidelines.
- 16 April 2013
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 26 (8) , 957-964
Open AccessThe Role of Plasma Renin Activity, Age, and Race in Selecting Effective Initial Drug Therapy for Hypertension
Strategies for initial drug therapy of hypertension are a thiazide diuretic for all or drug selection based on age/race criteria or on plasma renin activity (PRA). It is uncertain which of these strategies will achieve the highest control rate among patients with stage 1 essential hypertension. We sought to compare control rates among 3 drug selection strategies: (i) thiazide diuretic for all, (ii) thiazide diuretic for all black subjects and white subjects aged ≥50 years and a renin-angiotensin system blocker for white subjects aged P < 0.001) and 53.8% with the thiazide for all strategy (P < 0.001). This was also true in each racial subgroup (in black subjects: 62.1% vs. 55.2% for the other 2 strategies, P = 0.02; in white subjects: 76.3% vs. 67.1% with the age/race strategy (P < 0.001) and 52.4% with the thiazide for all strategy (P < 0.001)). This exploratory analysis suggests that choice of initial therapy for hypertension using a PRA strategy may be associated with higher control rates than alternative strategies recommended in current guidelines.
- Open Access
- 13 March 2012
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (1) , 47
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response
To determine whether office, home, ambulatory daytime and nighttime blood pressure (BP) responses to antihypertensive drug therapy measure the same signal and which method provides greatest power to identify genetic predictors of BP response. We analyzed office, home, ambulatory daytime and nighttime BP responses in hypertensive adults randomized to atenolol (N = 242) or hydrochlorothiazide (N = 257) in the Pharmacogenomic Evaluation of Antihypertensive Responses Study. Since different measured BP responses may have different predictors, we tested the "same signal" model by using linear regression methods to determine whether known predictors of BP response depend on the method of BP measurement. We estimated signal-to-noise ratios and compared power to identify a genetic polymorphism predicting BP response measured by each method separately and by weighted averages of multiple methods. After adjustment for pretreatment BP level, known predictors of BP response including plasma renin activity, race, and sex were independent of the method of BP measurement. Signal-to-noise ratios were more than 2-fold greater for home and ambulatory daytime BP responses than for office and ambulatory nighttime BP responses and up to 11-fold greater for weighted averages of all four methods. Power to identify a genetic polymorphism predicting BP response was directly related to the signal-to-noise ratio and, therefore, greatest with the weighted averages. Since different methods of measuring BP response to antihypertensive drug therapy measure the same signal, weighted averages of the BP responses measured by multiple methods minimize measurement error and optimize power to identify genetic predictors of BP response.
- 13 March 2012
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (1) , 47
Open AccessPower to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response
To determine whether office, home, ambulatory daytime and nighttime blood pressure (BP) responses to antihypertensive drug therapy measure the same signal and which method provides greatest power to identify genetic predictors of BP response. We analyzed office, home, ambulatory daytime and nighttime BP responses in hypertensive adults randomized to atenolol (N = 242) or hydrochlorothiazide (N = 257) in the Pharmacogenomic Evaluation of Antihypertensive Responses Study. Since different measured BP responses may have different predictors, we tested the "same signal" model by using linear regression methods to determine whether known predictors of BP response depend on the method of BP measurement. We estimated signal-to-noise ratios and compared power to identify a genetic polymorphism predicting BP response measured by each method separately and by weighted averages of multiple methods. After adjustment for pretreatment BP level, known predictors of BP response including plasma renin activity, race, and sex were independent of the method of BP measurement. Signal-to-noise ratios were more than 2-fold greater for home and ambulatory daytime BP responses than for office and ambulatory nighttime BP responses and up to 11-fold greater for weighted averages of all four methods. Power to identify a genetic polymorphism predicting BP response was directly related to the signal-to-noise ratio and, therefore, greatest with the weighted averages. Since different methods of measuring BP response to antihypertensive drug therapy measure the same signal, weighted averages of the BP responses measured by multiple methods minimize measurement error and optimize power to identify genetic predictors of BP response.
- 1 June 2007
- Published by Wolters Kluwer Health in Hypertension
- Vol. 49 (6) , 1228-1234
Association of Ambulatory Blood Pressure With Ischemic Brain Injury
Cerebral white matter hyperintensities on brain MRI (leukoaraiosis) are associated with increased risk of stroke and dementia. To assess the relationships of blood pressure level and circadian pattern with leukoaraiosis, we obtained 24-hour ambulatory blood pressure recordings and brain magnetic resonance images in 343 white and 267 black adults who were members of sibships that had ≥2 siblings with essential hypertension. In multiple linear regression models, factors associated with greater leukoaraiosis in both racial groups included age ( P ≤0.002), homocysteine levels ( P ≤0.006), and brain volume ( P ≤0.008). In blacks, ambulatory blood pressure measures associated with greater leukoaraiosis were higher awake, asleep, and 24-hour systolic and diastolic levels ( P ≤0.009 for each). In addition, there was a trend for smaller nocturnal declines in systolic and diastolic levels (ie, nondipping patterns) to be associated with greater leukoaraiosis, and all of these associations, except nondipping of diastolic level, remained or became significant after controlling for office blood pressure ( P P ≤0.008), and all of these associations remained or became significant after controlling for office blood pressure ( P ≤0.009 for each). Higher ambulatory blood pressure levels and a nondipping circadian pattern contribute to greater leukoaraiosis volume after controlling for office blood pressure.
- 1 June 2007
- Published by Wolters Kluwer Health in Hypertension
- Vol. 49 (6) , 1228-1234
Association of Ambulatory Blood Pressure With Ischemic Brain Injury
Cerebral white matter hyperintensities on brain MRI (leukoaraiosis) are associated with increased risk of stroke and dementia. To assess the relationships of blood pressure level and circadian pattern with leukoaraiosis, we obtained 24-hour ambulatory blood pressure recordings and brain magnetic resonance images in 343 white and 267 black adults who were members of sibships that had ≥2 siblings with essential hypertension. In multiple linear regression models, factors associated with greater leukoaraiosis in both racial groups included age ( P ≤0.002), homocysteine levels ( P ≤0.006), and brain volume ( P ≤0.008). In blacks, ambulatory blood pressure measures associated with greater leukoaraiosis were higher awake, asleep, and 24-hour systolic and diastolic levels ( P ≤0.009 for each). In addition, there was a trend for smaller nocturnal declines in systolic and diastolic levels (ie, nondipping patterns) to be associated with greater leukoaraiosis, and all of these associations, except nondipping of diastolic level, remained or became significant after controlling for office blood pressure ( P P ≤0.008), and all of these associations remained or became significant after controlling for office blood pressure ( P ≤0.009 for each). Higher ambulatory blood pressure levels and a nondipping circadian pattern contribute to greater leukoaraiosis volume after controlling for office blood pressure.
- 1 June 2005
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 7 (3) , 173-177
Treatment of leukoaraiosis
Altered signal intensity in the subcortical white matter on magnetic resonance imaging of the brain, referred to as leukoaraiosis, is frequently observed on imaging studies in elderly persons and was previously considered a benign accompaniment of aging. However, recent studies have found a clear association between the presence of leukoaraiosis and an increased risk for stroke, cognitive decline, and dementia. Moreover, epidemiologic studies have shown an association of leukoaraiosis with age, and several risk factors that are amenable to treatment, including smoking, hypertension, diabetes, homocysteinemia, hyperlipidemia, and excess alcohol use. Although results from prospective trials are not available, current evidence suggests that vigorous treatment of cardiovascular disease risk factors may prevent the development or progression of leukoaraiosis and the attendant risks of stroke and dementia.
- 1 June 2005
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 7 (3) , 173-177
Treatment of leukoaraiosis
Altered signal intensity in the subcortical white matter on magnetic resonance imaging of the brain, referred to as leukoaraiosis, is frequently observed on imaging studies in elderly persons and was previously considered a benign accompaniment of aging. However, recent studies have found a clear association between the presence of leukoaraiosis and an increased risk for stroke, cognitive decline, and dementia. Moreover, epidemiologic studies have shown an association of leukoaraiosis with age, and several risk factors that are amenable to treatment, including smoking, hypertension, diabetes, homocysteinemia, hyperlipidemia, and excess alcohol use. Although results from prospective trials are not available, current evidence suggests that vigorous treatment of cardiovascular disease risk factors may prevent the development or progression of leukoaraiosis and the attendant risks of stroke and dementia.
- 1 May 2005
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 18 (5) , A244
Diurnal blood pressure rhythm predicts ischemic brain damage
Altered signal intensity in the subcortical white matter on magnetic resonance imaging (MRI) of the brain, referred to as leukoaraiosis, arises from ischemic injury due to arteriolosclerosis of penetrating end arterioles and is associated with increased risk of stroke, cognitive decline and dementia. Elevated blood pressure (BP) and altered diurnal BP rhythm may be major risk factors. To assess the relationships of leukoaraiosis volume with measures of BP level and diurnal rhythm, we obtained brain MRI's and 24-hour ambulatory BP recordings (awake and asleep) in 198 adults (70 African Americans from Jackson MS and 128 non-Hispanic whites from Rochester MN; 123 women, 75 men; 62 ± 5.5 yrs old). In multiple regression analyses that considered age, gender, office BP, and ambulatory measures of BP level and diurnal rhythm, greater leukoaraiosis volume was significantly associated with older age (P P = 0.0475; diastolic, P = 0.0047), and smaller declines in BP between awake and asleep periods (i.e., non-dipping; systolic, P = 0.0080; diastolic, P = 0.0017). Measures of pulse pressure were not significantly associated with volume of leukoaraiosis. These data suggest that in addition to measures of BP level, the diurnal pattern of variation in BP levels influences the volume of leukoaraiosis. These observations could have important implications for the pharmacological therapy of hypertension to prevent the development or progression of leukoaraiosis and the attendant risks of stroke and dementia.
- 1 May 2005
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 18 (5) , A244
Diurnal blood pressure rhythm predicts ischemic brain damage
Altered signal intensity in the subcortical white matter on magnetic resonance imaging (MRI) of the brain, referred to as leukoaraiosis, arises from ischemic injury due to arteriolosclerosis of penetrating end arterioles and is associated with increased risk of stroke, cognitive decline and dementia. Elevated blood pressure (BP) and altered diurnal BP rhythm may be major risk factors. To assess the relationships of leukoaraiosis volume with measures of BP level and diurnal rhythm, we obtained brain MRI's and 24-hour ambulatory BP recordings (awake and asleep) in 198 adults (70 African Americans from Jackson MS and 128 non-Hispanic whites from Rochester MN; 123 women, 75 men; 62 ± 5.5 yrs old). In multiple regression analyses that considered age, gender, office BP, and ambulatory measures of BP level and diurnal rhythm, greater leukoaraiosis volume was significantly associated with older age (P P = 0.0475; diastolic, P = 0.0047), and smaller declines in BP between awake and asleep periods (i.e., non-dipping; systolic, P = 0.0080; diastolic, P = 0.0017). Measures of pulse pressure were not significantly associated with volume of leukoaraiosis. These data suggest that in addition to measures of BP level, the diurnal pattern of variation in BP levels influences the volume of leukoaraiosis. These observations could have important implications for the pharmacological therapy of hypertension to prevent the development or progression of leukoaraiosis and the attendant risks of stroke and dementia.
- Open Access
- 1 February 2005
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (2) , 386-394
Screening for Primary Aldosteronism in Essential Hypertension: Diagnostic Accuracy of the Ratio of Plasma Aldosterone Concentration to Plasma Renin Activity
Background: The ratio of plasma aldosterone concentration to plasma renin activity (PRA) is considered the screening test of choice for primary aldosteronism. Uncertainty exists, however, regarding its diagnostic accuracy and the effects of antihypertensive drugs and dietary sodium balance on test characteristics.
- 1 February 2005
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (2) , 386-394
Open AccessScreening for Primary Aldosteronism in Essential Hypertension: Diagnostic Accuracy of the Ratio of Plasma Aldosterone Concentration to Plasma Renin Activity
Background: The ratio of plasma aldosterone concentration to plasma renin activity (PRA) is considered the screening test of choice for primary aldosteronism. Uncertainty exists, however, regarding its diagnostic accuracy and the effects of antihypertensive drugs and dietary sodium balance on test characteristics.